首页> 美国卫生研究院文献>Infection and Immunity >Cholera Holotoxin Assembly Requires a Hydrophobic Domain at the A-B5 Interface: Mutational Analysis and Development of an In Vitro Assembly System
【2h】

Cholera Holotoxin Assembly Requires a Hydrophobic Domain at the A-B5 Interface: Mutational Analysis and Development of an In Vitro Assembly System

机译:霍乱全毒素大会在A-B5界面上需要一个疏水域:体外大会系统的突变分析和开发。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cholera toxin (CT) and related Escherichia coli enterotoxins LTI and LTIIb have a conserved hydrophobic region at the AB5 interface postulated to be important for toxin assembly. Hydrophobic residue F223 in the A subunit of CT (CTA) as well as residues 174, L77, and T78 in the B subunit of CT (CTB) were replaced individually with aspartic acid, and the resulting CTA and CTB variants were analyzed for their ability to assemble into holotoxin in vivo. CTA-F223D holotoxin exhibited decreased stability and toxicity and increased susceptibility to proteolysis by trypsin. CTB-L77D was unable to form functional pentamers. CTB-I74D and CTB-T78D formed pentamers that bound to GM1 and d-galactose but failed to assemble with CTA to form holotoxin. In contrast, CTB-T78D and CTA-F223H interacted with each other to form a significant amount of holotoxin in vivo. Our findings support the importance of hydrophobic interactions between CTA and CTB in holotoxin assembly. We also developed an efficient method for assembly of CT in vitro, and we showed that CT assembled in vitro was comparable to wild-type CT in toxicity and antigenicity. CTB-I74D and CTB-T78D did not form pentamers or holotoxin in vitro, and CTA-F223D did not form holotoxin in vitro. The efficient system for in vitro assembly of CT described here should be useful for future studies on the development of drugs to inhibit CT assembly as well as the development of chimeric CT-like molecules as potential vaccine candidates.
机译:霍乱毒素(CT)和相关的大肠杆菌肠毒素LTI和LTIIb在AB5界面处有一个保守的疏水区,据推测对毒素组装很重要。用天冬氨酸分别置换CT(CTA)A亚基中的疏水残基F223和CT B CT(CTB)B亚基中的残基174,L77和T78,并分析所得CTA和CTB变异体的能力在体内组装成全毒素CTA-F223D全毒素显示出降低的稳定性和毒性,并增加了胰蛋白酶对蛋白水解的敏感性。 CTB-L77D无法形成功能性五聚体。 CTB-I74D和CTB-T78D形成与GM1和d-半乳糖结合但不能与CTA组装形成全毒素的五聚体。相反,CTB-T78D和CTA-F223H在体内相互作用形成大量的全毒素。我们的发现支持了CTA和CTB在全毒素装配中疏水相互作用的重要性。我们还开发了一种在体外组装CT的有效方法,我们证明了在体外组装CT的毒性和抗原性与野生型CT相当。 CTB-I74D和CTB-T78D在体外不形成五聚体或全毒素,而CTA-F223D在体外不形成全毒素。此处描述的有效的体外CT组装系统对于将来开发抑制CT组装的药物以及开发作为潜在疫苗候选物的嵌合CT样分子的研究应该是有用的。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号